Amicus Therapeutics (FOLD) Q3 Earnings and Revenues Beat Estimates

Amicus Therapeutics (FOLD) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of$ 0.08 per share. This compares to loss of $0.07 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 25%. A quarter ago, it was expected that this pharmaceutical company would post earnings of$ 0.03 per share when it actually produced earnings of $0.06, delivering a surprise of 100%.Over the last four quarters, th ...